Search Results 741-750 of 18472 for prednisone

  1. Clinical trials - Oncology (Medical)

    ... prednisone, thioguanine, vincristine, and pegaspargase work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping ...

  2. Mayo Clinic Q and A: Decongestants can sometimes cause more harm than good

    In addition, using nonprescription decongestant nasal sprays for more than three or four days can cause worse nasal congestion once the decongestant wears off, ...

  3. COVID-19 drugs: Are there any that work? - Mayo Clinic

    Baricitinib, a pill, seems to treat COVID-19 as an antiviral medicine and by lowering inflammation. Tocilizumab is a shot, also called an injection, that seems ...

  4. A Study to Analyze CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma - Mayo Clinic

    ... prednisone within 30 days before first dose of study treatment on W1D1. Subjects who are currently receiving steroids at a prednisone-equivalent dose of ...

  5. A Study to Assess the Aria CV Pulmonary Hypertension System to Treat Pulmonary Arterial Hypertension - Mayo Clinic

    ... Prednisone at a dose \> 12 mg per day at time of enrollment; ii. Excluded if any immunosuppressant other than Mycophenolate mofetil, Rituximab or Prednisone ...

  6. (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis - Mayo Clinic

    Eastern Cooperative Oncology Group (ECOG) Performance Status 0 to 2. For patients receiving corticosteroids, the dose must be ≤ 10 mg/day of prednisone or ...

  7. Symptoms and causes - Mayo Clinic

    Long-term use of corticosteroid medicines, such as prednisone and cortisone, interferes with the bone-rebuilding process. These medicines are taken by mouth ...

  8. Oncology (Medical) - Clinical trials

    ... prednisone, thioguanine, vincristine, and pegaspargase work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping ...

  9. Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) - Mayo Clinic

    ... prednisone, and Cohort C will receive pembrolizumab + enzalutamide. Outcome measures will be assessed individually for each cohort. Participation ...

  10. Aldesleukin (intravenous route) - Side effects & uses - Mayo Clinic

    Ebola Zaire Vaccine, Live; Hydrocortisone; Influenza Virus Vaccine, Live; Methylprednisolone; Paramethasone; Prednisolone; Prednisone; Rotavirus Vaccine, Live ...